Workflow
珠免集团(600185) - 2025 Q3 - 季度财报
2025-10-29 11:00
Financial Performance - The company's operating revenue for the third quarter was ¥756,747,488.74, a decrease of 35.41% compared to the same period last year[5]. - The total profit for the quarter was -¥171,036,227.96, with a year-to-date total profit of -¥59,034,465.76[5]. - The net profit attributable to shareholders was -¥290,804,357.47 for the quarter, and -¥565,017,516.92 year-to-date[5]. - Total operating revenue for the first three quarters of 2025 was CNY 2,496,335,302.26, a decrease of 42.6% compared to CNY 4,370,434,178.01 in the same period of 2024[20]. - Net profit for the first three quarters of 2025 was a loss of CNY 296,834,576.43, compared to a loss of CNY 271,622,667.03 in the same period of 2024[21]. - The total comprehensive income for the first three quarters of 2025 was a loss of CNY 352,649,184.46, compared to a loss of CNY 284,453,716.16 in the same period of 2024[22]. Cash Flow - The net cash flow from operating activities was ¥130,502,127.93, a decrease of 58.44% year-to-date[5]. - Net cash flow from operating activities for the first three quarters of 2025 was $353.16 million, down 58.5% from $849.72 million in 2024[25]. - Cash outflow from operating activities totaled $2.41 billion in the first three quarters of 2025, compared to $2.96 billion in 2024, indicating a decrease of 17.5%[25]. - Cash inflow from investment activities in the first three quarters of 2025 was $586.37 million, an increase of 58.0% compared to $370.95 million in 2024[25]. - Net cash flow from investment activities for the first three quarters of 2025 was $510.99 million, contrasting with a slight outflow of $1.17 million in 2024[25]. - Total cash inflow from financing activities in the first three quarters of 2025 was approximately $6.60 billion, an increase of 21.1% from $5.45 billion in 2024[25]. - Net cash flow from financing activities for the first three quarters of 2025 was negative at $1.93 billion, compared to a negative $944.08 million in 2024[25]. - The ending cash and cash equivalents balance as of the end of the third quarter of 2025 was approximately $3.57 billion, down from $4.74 billion at the end of the same period in 2024[25]. Assets and Liabilities - The total assets at the end of the reporting period were ¥17,260,174,045.38, down 11.73% from the end of the previous year[6]. - The total liabilities decreased from CNY 16,110,137,980.69 in the previous year to CNY 14,166,438,094.73, reflecting a reduction of approximately 12.0%[18]. - The total equity attributable to shareholders decreased from CNY 1,164,654,868.63 to CNY 572,523,170.52, a decline of about 50.8%[18]. - Cash and cash equivalents are reported at ¥3,891,215,895.34, down from ¥5,064,954,792.24 in the previous year[16]. - Inventory stands at ¥7,806,478,874.46, compared to ¥8,193,988,147.39 in the previous year[16]. - The company has reported a short-term loan of ¥5,632,533,433.53, an increase from ¥4,959,389,702.40 in the previous year[17]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 58,131[12]. - The largest shareholder, Zhuhai Investment Holdings Co., Ltd., holds 847,339,780 shares, accounting for 44.95% of total shares[12]. Strategic Focus - The significant decrease in operating revenue was primarily due to reduced revenue from real estate project completions[9]. - The net cash flow from operating activities was negatively impacted by a decrease in sales collections[9]. - The company plans to transfer 100% equity of Zhuhai Gree Real Estate Co., Ltd. to Zhuhai Tojie Holdings Co., Ltd., marking a significant asset restructuring[15]. - The company is focusing on de-emphasizing real estate and concentrating on duty-free and consumer business sectors[15]. Earnings Per Share - The basic and diluted earnings per share for the quarter were both -¥0.15[6]. - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY -0.30, compared to CNY -0.31 in the same period of 2024[22]. Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 2,177,117.33, a decrease from CNY 2,658,286.88 in 2024[20]. Investment Performance - The company reported an investment loss of CNY 31,087,984.57 in the first three quarters of 2025, compared to a gain of CNY 25,935,773.97 in the same period of 2024[20]. - Other comprehensive income after tax for the first three quarters of 2025 was a loss of CNY 55,814,608.03, compared to a loss of CNY 12,831,049.13 in 2024[21]. Accounting Standards - The company will not apply new accounting standards starting from 2025[26].
山水比德(300844) - 2025 Q3 - 季度财报
2025-10-29 10:55
Financial Performance - The company's revenue for Q3 2025 was ¥77,638,032.47, a decrease of 27.31% compared to the same period last year[5] - The net profit attributable to shareholders was -¥39,436,426.38, representing a decline of 564.27% year-on-year[5] - The basic earnings per share were -¥0.44, down 588.89% from the previous year[5] - Total operating revenue for the third quarter reached ¥302,820,599.84, an increase of 5.8% compared to ¥286,982,201.72 in the previous period[33] - Net profit for the third quarter was a loss of ¥36,324,957.80, compared to a profit of ¥19,605,210.06 in the same period last year[34] - The total comprehensive income for the current period is -36,335,559.75, compared to 19,605,210.06 in the previous period, indicating a significant decline[35] - The basic and diluted earnings per share for the current period are both -0.41, down from 0.23 in the previous period[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥966,274,090.64, an increase of 2.50% from the end of the previous year[5] - The company's total assets as of September 30, 2025, were ¥966,274,090.64, an increase from ¥942,749,138.84 at the beginning of the period[30] - Current liabilities rose to ¥226,518,681.51, up from ¥164,564,122.78 at the start of the period, reflecting a significant increase in short-term borrowings[30] - The total equity attributable to shareholders decreased to ¥733,234,336.06 from ¥769,132,196.45, reflecting a decline in retained earnings[31] Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥33,712,303.19, a decrease of 38.88% compared to the previous year[5] - Cash inflows from operating activities totaled 315,816,227.84, an increase from 242,285,716.94 in the previous period[37] - Cash outflows from operating activities amounted to 349,528,531.03, compared to 266,560,303.42 in the previous period, resulting in a net cash flow from operating activities of -33,712,303.19[38] - Cash inflows from investing activities were 261,358,641.85, up from 133,281,217.80 in the previous period[38] - Cash outflows from investing activities increased to 467,063,407.87 from 268,607,655.27 in the previous period, leading to a net cash flow from investing activities of -205,704,766.02[38] - Cash inflows from financing activities reached 100,040,000.00, compared to 30,540,000.00 in the previous period[38] - Cash outflows from financing activities decreased to 31,570,467.52 from 37,627,917.11 in the previous period, resulting in a net cash flow from financing activities of 68,469,532.48[38] - The ending cash and cash equivalents balance is 276,081,971.83, compared to 185,697,752.31 in the previous period[38] Shareholder Information - The total number of common shareholders at the end of the reporting period is 6,343[14] - The largest shareholder, Shanshui Bide Group, holds 39.17% of shares, totaling 36,512,000 shares[14] - The second-largest shareholder, Sun Hu, owns 20.43% of shares, amounting to 19,040,000 shares[14] - The total number of restricted shares at the beginning of the period was 42,125,000, with 39,860,000 shares released during the period[17] - The number of shares held by the top ten shareholders does not include shares lent through margin trading[15] - The total number of shares held by the top ten unrestricted shareholders is 66,000,000[15] - The company has no preferred shareholders or related changes in preferred stock ownership[16] Stock Option Incentive Plan - The company has implemented a stock option incentive plan for 2025, granting a total of 2.705 million stock options, which is 2.99% of the company's total share capital[18] - The first grant under the incentive plan consists of 2.345 million stock options, representing 86.69% of the total options granted[18] - The company has reserved 360,000 stock options for future grants, which is 0.4% of the total share capital[18] - The company approved the 2025 Stock Option Incentive Plan, granting 2.345 million stock options at an exercise price of 43.81 CNY per option to 78 incentive recipients[20] - As of September 15, 2025, all 39 eligible incentive recipients exercised a total of 2.71488 million shares, increasing the total share capital from 90.496 million shares to 93.21088 million shares[23] - The exercise price for the 2024 Stock Option Incentive Plan was adjusted from 29.68 CNY to 21.2 CNY per share, with the number of options increased from 3.8784 million to 5.42976 million[22] - The company's controlling shareholder's stake was diluted from 74.85% to 72.94% due to the stock option exercise, a change that touched a 1% integer multiple[24] Strategic Investments and Business Operations - The company's inventory increased by 176.72% to ¥9,139,214.66, attributed to the expansion of EPC business scale[9] - The company reported a 33.56% increase in operating costs, totaling ¥185,210,266.57, mainly due to higher design personnel costs and new EPC business costs[10] - Cash received from sales increased by 33.15% to ¥309,524,114.96, driven by improved collection rates[12] - The company made strategic investments totaling ¥460,000,000.00, a 76.92% increase compared to the previous year, indicating a focus on external strategic investments[12] - Research and development expenses for the quarter were ¥25,762,975.92, slightly up from ¥25,504,637.44 in the previous period, indicating continued investment in innovation[33] Fundraising and Financial Management - The company approved adjustments to the internal investment structure and extended the expected completion date for several fundraising projects to August 31, 2028[25] - A new special account for raised funds was established at CITIC Bank for the storage, use, and management of funds related to fundraising projects[26] - The company appointed a new sponsor representative to ensure ongoing supervision of the IPO process, with the supervision period ending on December 31, 2024[28] Audit Status - The financial report for the third quarter has not been audited[40]
迪阿股份(301177) - 2025 Q3 - 季度财报
2025-10-29 10:55
迪阿股份有限公司 2025 年第三季度报告 证券代码:301177 证券简称:迪阿股份 公告编号:2025-058 迪阿股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 迪阿股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比 | | --- | --- | --- | --- | --- | | | | 增减 | | 上年同期增减 | | 营业收入(元) | 370,315,196.21 | 11.17% | 1,156,382,612.03 ...
万邦德(002082) - 2025 Q3 - 季度财报
2025-10-29 10:55
Financial Performance - The company's revenue for Q3 2025 was CNY 439,154,394.07, representing a 36.51% increase compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 8,995,682.80, a decrease of 212.42% year-on-year[5]. - Total operating revenue for the current period was ¥1,017,706,438.36, a decrease of 5.1% compared to ¥1,074,491,139.98 in the previous period[24]. - The company's net profit for the current period is CNY 1,284,622.12, a significant decrease from CNY 36,246,556.95 in the previous period, representing a decline of approximately 96.45%[25]. - Operating profit for the current period is CNY 1,041,807.60, down from CNY 40,409,653.41 in the previous period, indicating a decrease of about 97.42%[25]. - The company's total comprehensive income for the current period is CNY 10,027,715.24, down from CNY 53,435,233.57 in the previous period, a decrease of approximately 81.24%[25]. - Basic and diluted earnings per share for the current period are both CNY 0.0100, a significant drop from CNY 0.0741 in the previous period[25]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was CNY 36,573,031.31, down 73.15% compared to the previous year[5]. - The company's cash and cash equivalents decreased from CNY 158,726,728.80 at the beginning of the period to CNY 83,070,795.97 at the end of the period, a decline of approximately 47.7%[20]. - Cash flow from operating activities for the current period is CNY 36,573,031.31, a decrease of 73.14% compared to CNY 136,224,725.34 in the previous period[26]. - Cash flow from investing activities shows a net outflow of CNY 287,768,022.83, worsening from a net outflow of CNY 193,233,025.70 in the previous period[27]. - Cash flow from financing activities resulted in a net inflow of CNY 179,098,407.90, compared to a net outflow of CNY 87,175,082.75 in the previous period, indicating a positive shift[27]. - The cash and cash equivalents at the end of the period amount to CNY 71,370,795.93, a slight decrease from CNY 73,766,560.85 in the previous period[27]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,541,970,797.02, an increase of 4.96% from the end of the previous year[5]. - Current assets totaled ¥1,742,675,531.54, a slight decrease from ¥1,803,320,380.71 in the previous period[21]. - Non-current assets increased to ¥2,799,295,265.48 from ¥2,524,076,699.82, reflecting a growth of 10.8%[21]. - Total liabilities rose to ¥1,775,399,359.75, compared to ¥1,570,954,359.63 in the previous period, indicating an increase of 13.0%[22]. - Total equity attributable to shareholders was ¥2,674,894,570.54, slightly up from ¥2,666,804,346.48[22]. - Long-term borrowings increased to ¥153,433,064.20 from ¥104,000,000.00, representing a growth of 47.5%[22]. - The company reported a decrease in short-term borrowings to ¥692,652,830.16 from ¥853,969,430.11, a reduction of 18.8%[22]. - Deferred tax assets increased to ¥150,623,375.37 from ¥134,444,446.98, showing a growth of 12.0%[21]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 26,415[12]. - The largest shareholder, Wanbangde Group Co., Ltd., holds 31.62% of the shares, with 153,150,000 shares pledged[12]. - The controlling shareholder and its concerted actors transferred a total of 60 million shares, accounting for 9.8089% of the company's total share capital, to a partnership on October 13, 2025[18]. - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending activities[18]. Research and Development - Research and development expenses increased by 34.25% to CNY 71,623,824.70, reflecting higher investment in innovative drug development[10]. - Wanbangde Pharmaceutical obtained invention patents for compositions and formulations for treating Alzheimer's disease and skin photoaging, as well as for a disulfide cyclic peptide compound and its preparation methods[14]. - The company completed the first subject enrollment for the Phase II/III clinical trial of the new drug Huperzine A controlled-release tablets for treating mild to moderate Alzheimer's disease[15]. - The Phase II/III clinical trial received ethical approval from the Capital Medical University Xuanwu Hospital's ethics review committee, allowing collaboration with over 50 research institutions nationwide[17]. Government Subsidies - The company reported a significant increase in government subsidies, with CNY 1,719,364.84 recognized in the current period[7]. Revenue and Costs - The company experienced a decline in revenue and net profit primarily due to the failure to win bids for key products in national procurement[5]. - Total operating costs for the current period were ¥1,058,426,407.78, down 1.7% from ¥1,077,232,284.96 in the previous period[24]. - Operating costs included ¥689,033,168.53 in operating expenses, which increased from ¥638,499,206.00 in the previous period[24]. - Total revenue from sales of goods and services received in cash is CNY 809,415,293.19, down from CNY 1,058,777,535.36, reflecting a decline of approximately 23.51%[26]. Accounts and Inventory - Accounts receivable increased from CNY 681,903,501.91 to CNY 728,378,485.73, reflecting a growth of about 6.8%[20]. - Inventory rose from CNY 213,858,705.73 to CNY 248,924,311.07, indicating an increase of approximately 16.4%[20]. - Prepayments increased from CNY 335,327,642.24 to CNY 374,423,888.23, representing an increase of about 11.6%[20]. - Other receivables increased significantly from CNY 18,567,129.32 to CNY 51,554,753.86, a growth of approximately 177.5%[20].
恩威医药(301331) - 2025 Q3 - 季度财报
2025-10-29 10:55
Financial Performance - The company's revenue for Q3 2025 was ¥187,632,107.25, representing an increase of 8.97% year-over-year[5]. - Total operating revenue for the period reached ¥636,853,560, an increase of 13.6% compared to ¥560,341,100.40 in the previous period[20]. - Net profit for the period was ¥36,584,661.67, representing a significant increase of 66.5% from ¥22,021,962.58 in the prior period[21]. - Basic earnings per share increased to ¥0.3668, compared to ¥0.2183 in the previous period, marking a growth of 67.9%[22]. Profitability and Losses - The net profit attributable to shareholders was a loss of ¥1,759,519.58, a decrease of 143.05% compared to the same period last year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of ¥3,403,801.61, down 164.61% year-over-year[5]. - The company reported a weighted average return on equity of -0.16% for the current period, down 0.53% year-over-year[5]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,496,708,751.53, a decrease of 0.52% from the end of the previous year[5]. - Total liabilities decreased to ¥413,060,476.78 from ¥446,857,834.56, a reduction of 7.6%[19]. - The total non-current assets included investment properties valued at ¥26,678,462.45, down from ¥28,476,170.60, a decrease of about 6.3%[17]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,340, with the largest shareholder holding 28.90% of the shares[11]. - The total number of shares held by the top 10 shareholders amounted to 69,790,184 shares, with significant holdings from Chengdu Enwei Investment Group Co., Ltd. at 29,733,200 shares[15]. - The company’s major shareholders are identified as acting in concert, controlling approximately 69.01% of the shares collectively[15]. Cash Flow and Investments - The cash flow from operating activities for the year-to-date was ¥76,202,035.01, an increase of 6.63% compared to the previous year[5]. - Total cash inflow from investment activities was $1,267,294,447.06, significantly higher than $640,603,505.93, marking an increase of approximately 97.8%[24]. - Net cash flow from investment activities was -$79,417,346.60, worsening from -$13,484,580.01 in the prior period[24]. Operational Metrics - Total operating costs amounted to ¥603,849,773.06, up from ¥534,869,746.20, reflecting a rise of 12.9%[20]. - The company experienced a 41.88% increase in trading financial assets, totaling ¥205,329,905.69, due to increased investment in financial products[10]. - The company reported a significant increase in investment income of 72.51%, amounting to ¥4,140,865.67, attributed to higher returns from financial products[10]. Strategic Focus - The company is focusing on expanding its market presence and investing in new product development to drive future growth[20]. - Research and development expenses were reported at ¥4,302,882.29, down from ¥5,770,697.03, indicating a strategic shift in resource allocation[20]. Cash Management - Cash and cash equivalents decreased to ¥319,607,373.19 from ¥370,274,493.59, reflecting a decline of about 13.7%[17]. - The ending balance of cash and cash equivalents stood at $259,566,279.03, down from $365,428,864.02[24]. - The net increase in cash and cash equivalents was -$29,657,510.52, contrasting with a positive increase of $129,612,081.81 in the previous period[24]. Accounting and Auditing - The company did not undergo an audit for the third quarter financial report[25]. - The company plans to implement new accounting standards starting in 2025[26].
海南海药(000566) - 2025 Q3 - 季度财报
2025-10-29 10:55
Financial Performance - The company's operating revenue for Q3 2025 was ¥189,408,874.14, a decrease of 10.36% compared to the same period last year[5] - The net profit attributable to shareholders was -¥84,000,150.87, with a year-to-date loss of -¥242,307,257.15[5] - The basic and diluted earnings per share were both -¥0.0647 for the current period[5] - Total operating revenue for the current period is CNY 639,683,832.92, a decrease of 20.5% compared to CNY 804,727,228.88 in the previous period[21] - The company reported a net loss of ¥262,645,523.82 for the current period, compared to a net loss of ¥313,678,925.17 in the previous period, representing an improvement of approximately 16.3%[22] - Operating profit (loss) for the current period was ¥-258,156,904.69, compared to ¥-305,059,177.96 in the previous period, indicating a reduction in losses by about 15.3%[22] - The company’s total comprehensive loss for the current period was ¥263,166,228.46, compared to a loss of ¥314,027,001.89 in the previous period, showing an improvement of about 16.3%[22] - Basic and diluted earnings per share were both reported at ¥-0.1868, an improvement from ¥-0.2275 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,790,095,764.09, down 5.29% from the end of the previous year[5] - The equity attributable to shareholders decreased by 47.01% to ¥278,371,317.30 compared to the previous year-end[5] - Current liabilities increased to CNY 4,359,829,200.30 from CNY 4,299,131,641.34, indicating a rise of 1.4%[19] - The company's total liabilities decreased to CNY 5,467,732,524.80 from CNY 5,523,151,531.94, a decrease of 1.0%[19] - The company's cash and cash equivalents decreased to CNY 259,728,662.81 from CNY 329,624,399.72, a decline of 21.1%[18] - Long-term equity investments slightly decreased to CNY 422,800,067.93 from CNY 429,519,914.71, a reduction of 1.6%[18] Cash Flow - Cash flow from operating activities for the year-to-date was ¥25,873,667.52, showing a significant improvement from -¥67,262,673.90 in the same period last year[9] - Cash flow from operating activities generated a net inflow of ¥25,873,667.52, a significant recovery from a net outflow of ¥67,262,673.90 in the previous period[23] - The company received cash from financing activities amounting to ¥2,303,823,616.13, compared to ¥3,048,072,741.84 in the previous period, reflecting a decrease of approximately 24.4%[24] - The company’s cash outflow from investing activities was ¥117,272,070.86, slightly down from ¥129,324,421.62 in the previous period[23] Expenses - Research and development expenses decreased by 52.86% to ¥27,335,705.41 compared to the previous year[9] - Sales expenses were reduced by 44.45% to ¥113,371,830.98, indicating effective control over market development costs[9] - The company's research and development expenses decreased to CNY 27,335,705.41 from CNY 57,982,852.49, a reduction of 52.9%[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 74,037[11] - The largest shareholder, Hainan Huadong Industrial Co., Ltd., holds 22.89% of shares, totaling 296,989,889 shares, with 148,494,944 shares pledged[11] - Shenzhen Nanfang Tongzheng Investment Co., Ltd. holds 10.28% of shares, totaling 133,346,318 shares, with 130,825,900 shares frozen[11] - Yunnan International Trust Co., Ltd. holds 5.26% of shares, totaling 68,295,512 shares[11] Legal and Financial Obligations - The company is pursuing legal action against Southern Tongzheng and others for a total debt of 311,169,942.04 RMB plus interest[15] - The company has a total of 101 properties mortgaged as collateral, with priority after certain banks[14] - The company has signed multiple agreements regarding debt transfer and compensation since December 2020[16] Other Financial Metrics - The company reported a significant increase in other payables by 75.84% to ¥1,898,667,712.80, primarily due to financial support from the controlling shareholder[9] - The company recorded a net investment income of ¥6,038,962.20, a recovery from a loss of -¥50,014,917.00 in the previous year[9] - The company's net investment income is CNY 6,038,962.20, a significant recovery from a loss of CNY 50,014,917.00 in the previous period[21] - The total assets decreased to CNY 5,790,095,764.09 from CNY 6,113,528,499.69, representing a decline of 5.3%[20] - The company's other comprehensive income after tax attributable to the parent company was ¥-520,704.64, compared to ¥-348,076.72 in the previous period, indicating a decline in comprehensive income[22]
航锦科技(000818) - 2025 Q3 - 季度财报
2025-10-29 10:55
Financial Performance - The company's revenue for Q3 2025 was ¥1,070,468,763.62, representing a decrease of 6.74% compared to the same period last year[7] - Net profit attributable to shareholders was ¥1,464,680.68, down 81.14% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥6,655,115.88, a decline of 5.21% compared to the previous year[7] - Total operating revenue for the third quarter of 2025 reached CNY 3,286,566,122.75, an increase from CNY 3,241,732,255.10 in the same period last year, representing a growth of approximately 1.4%[23] - Net profit for the period was CNY 67,157,576.55, down from CNY 102,565,455.03 year-over-year, indicating a decline of about 34.5%[24] - Operating profit for the period was CNY 105,924,093.15, down from CNY 116,605,404.65, representing a decrease of about 9.3%[24] - The company reported a decrease in basic earnings per share to CNY 0.02 from CNY 0.06, reflecting a decline of 66.7%[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥8,619,449,711.55, an increase of 0.91% from the end of the previous year[7] - Total current assets decreased from 3,788,227,522.05 CNY to 3,433,260,133.21 CNY, a decline of approximately 9.36%[20] - Total liabilities amounted to CNY 5,857,418,082.14, slightly up from CNY 5,824,079,448.51, showing an increase of about 0.6%[22] - The company's total assets increased to CNY 8,619,449,711.55 from CNY 8,541,999,872.43, reflecting a growth of approximately 0.9%[22] - The total equity attributable to shareholders of the parent company increased to CNY 2,309,712,193.50 from CNY 2,294,445,620.37, a growth of approximately 0.7%[22] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥781,036,521.74, a significant increase of 1,470.62%[7] - Operating cash flow for the current period reached ¥781,036,521.74, a significant improvement from a negative cash flow of ¥56,983,999.38 in the previous period[26] - Total cash inflow from operating activities was ¥3,987,686,658.57, compared to ¥2,629,130,180.28 in the prior period, reflecting a year-over-year increase of approximately 51.5%[26] - Cash outflow from investing activities totaled ¥1,390,983,733.60, a decrease from ¥1,595,362,389.95 in the previous period, indicating a reduction in investment expenditures[26] - Net cash flow from financing activities was ¥113,506,797.30, down from ¥1,955,012,038.81 in the prior period, showing a decline of approximately 94.2%[27] - The company's cash and cash equivalents at the end of the period stood at ¥695,734,834.90, down from ¥924,793,330.10 at the end of the previous period[27] Shareholder Information - Total number of common shareholders at the end of the reporting period is 124,143[15] - The largest shareholder, Wuhan New Energy Industrial Development Co., Ltd., holds 17.18% of shares, totaling 113,363,924 shares[15] - The second-largest shareholder, Xinyu Haoyue Information Technology Co., Ltd., holds 9.84% of shares, totaling 64,968,276 shares, with 51,190,000 shares pledged[15] Expenses - The company’s sales expenses increased by 65% to ¥63,824,724.82, mainly due to higher marketing costs[13] - The company’s financial expenses rose by 75% to ¥126,762,657.39, driven by an increase in financing scale[13] - Research and development expenses were CNY 148,272,025.18, down from CNY 171,764,028.99, indicating a decrease of about 13.6%[23] Changes in Assets - Cash and cash equivalents decreased from 1,341,940,752.59 CNY to 757,571,609.16 CNY, a decline of approximately 43.3%[20] - Accounts receivable increased from 657,544,884.69 CNY to 745,623,148.04 CNY, an increase of approximately 13.36%[20] - Inventory decreased from 786,984,174.79 CNY to 642,913,001.76 CNY, a decline of approximately 18.3%[20] - Long-term equity investments decreased slightly from 21,600,922.65 CNY to 21,184,806.06 CNY[20] - Fixed assets increased significantly from 2,619,788,191.25 CNY to 3,546,172,117.06 CNY, an increase of approximately 35.3%[20] Board of Directors - The company completed the election of the new board of directors, consisting of 9 members, including 5 non-independent directors and 3 independent directors[18] Audit Information - The company did not undergo an audit for the third quarter financial report[28]
金富科技(003018) - 2025 Q3 - 季度财报
2025-10-29 10:55
金富科技股份有限公司 2025 年第三季度报告 证券代码:003018 证券简称:金富科技 公告编号:2025-039 金富科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 金富科技股份有限公司 2025 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 期增减 | | 比上年同期增减 | | 营业收入(元) | 256,988,629.78 | -2.69% | 661,684,26 ...
德尔未来(002631) - 2025 Q3 - 季度财报
2025-10-29 10:55
Revenue and Profitability - The company's revenue for Q3 2025 was ¥308,170,664.89, representing a decrease of 31.23% compared to the same period last year[5] - The net profit attributable to shareholders was -¥13,770,304.07, a decline of 154.60% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥19,890,737.50, down 267.87% from the previous year[5] - Total operating revenue for the current period was ¥831,387,695.64, a decrease of 26.3% from ¥1,128,850,710.49 in the previous period[23] - Net profit for the current period was a loss of ¥70,094,716.98, compared to a profit of ¥1,457,751.70 in the previous period[24] - The company reported a basic and diluted earnings per share of -0.0889, compared to 0.0019 in the previous period[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,284,245,241.03, a decrease of 12.24% from the end of the previous year[5] - Total current assets decreased from CNY 2,745,129,991.59 to CNY 2,619,312,262.67, a decline of approximately 4.6%[17] - Total assets decreased from CNY 3,742,356,609.49 to CNY 3,284,245,241.03, a decline of approximately 12.3%[19] - Total liabilities decreased to ¥1,090,842,221.50 from ¥1,478,858,872.99 in the previous period, reflecting a reduction of 26.2%[21] - Total equity attributable to shareholders decreased to ¥2,187,174,957.31 from ¥2,258,076,240.45, a decline of 3.1%[21] Cash Flow - Cash flow from operating activities for the year-to-date was -¥138,805,386.98, a decline of 263.71%[5] - The net cash flow from operating activities was negative at ¥138,805,386.98, a significant decline from a positive cash flow of ¥84,789,048.68 in the previous period[26] - Cash inflow from investment activities increased to ¥8,255,291,783.73, up from ¥6,509,377,902.58 in the previous period[26] - Cash outflow from investment activities totaled $8,689,102,898.70, an increase from $7,412,406,353.60 in the previous period, reflecting a significant investment strategy[27] - Net cash flow from investment activities was -$433,811,114.97, improving from -$903,028,451.02 year-over-year[27] - Cash inflow from financing activities amounted to $290,276,688.49, down from $568,273,260.22 in the prior period[27] - Net cash flow from financing activities was $81,150,476.86, a turnaround from -$183,621,504.84 in the previous year[27] - The net increase in cash and cash equivalents was -$491,464,527.31, compared to -$1,001,859,478.64 in the same period last year[27] - The ending balance of cash and cash equivalents was $328,222,573.80, up from $195,767,755.25 year-over-year[27] Financial Position Changes - The company reported a significant increase in financial assets, with trading financial assets rising by 225.64% compared to the previous year-end[8] - The company experienced a 91.16% decrease in financial expenses due to the redemption of convertible bonds[9] - Cash received from the sale of goods and services decreased by 34% year-on-year, primarily due to reduced sales revenue[12] - The company recorded a 2535% increase in cash received from the disposal of fixed assets, indicating a significant rise in idle asset sales[12] - Cash and cash equivalents dropped significantly from CNY 967,956,463.37 to CNY 363,935,676.35, representing a decrease of about 62.4%[17] - Trading financial assets increased from CNY 309,064,359.90 to CNY 1,006,445,270.59, marking a growth of approximately 225.3%[17] - Inventory decreased from CNY 636,169,436.88 to CNY 474,743,901.26, a reduction of about 25.4%[17] - Short-term borrowings decreased from CNY 350,207,045.55 to CNY 271,272,434.44, a reduction of about 22.6%[19] - Accounts payable decreased from CNY 259,731,603.34 to CNY 236,611,055.66, a decline of approximately 8.9%[19] - Contract liabilities decreased from CNY 592,818,673.75 to CNY 399,164,676.02, a reduction of about 32.7%[19] Corporate Actions and Future Outlook - The company completed the cancellation of Wuxi Huicheng Graphene Technology Application Co., Ltd. on August 21, 2025, which had no significant impact on overall operations and performance[15] - The company reported a total of 42,225 preferred shareholders at the end of the reporting period[14] - The company’s research and development expenses were ¥20,941,837.43, down from ¥23,267,485.63 in the previous period, indicating a decrease of 9.9%[23] - The third quarter financial report was not audited, indicating potential areas for further scrutiny[28] - The company plans to implement new accounting standards starting in 2025, which may impact future financial reporting[29]
怡亚通(002183) - 2025 Q3 - 季度财报
2025-10-29 10:55
深圳市怡亚通供应链股份有限公司 2025 年第三季度报告 证券代码:002183 证券简称:怡亚通 公告编号:2025-105 深圳市怡亚通供应链股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | 营业收入(元) | 16,302,794,926.00 | -8.45% | 52,263,295,974.00 ...